| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |